TERRASCEND CORP (TSND.CA) Fundamental Analysis & Valuation
TSX:TSND • CA88105E1088
Current stock price
0.89 CAD
-0.02 (-2.2%)
Last:
This TSND.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. TSND.CA Profitability Analysis
1.1 Basic Checks
- TSND had negative earnings in the past year.
- TSND had a positive operating cash flow in the past year.
- TSND had negative earnings in 4 of the past 5 years.
- In multiple years TSND reported negative operating cash flow during the last 5 years.
1.2 Ratios
- Looking at the Return On Assets, with a value of -15.47%, TSND is doing worse than 64.52% of the companies in the same industry.
- With a Return On Equity value of -88.45%, TSND is not doing good in the industry: 77.42% of the companies in the same industry are doing better.
- TSND's Return On Invested Capital of 6.19% is amongst the best of the industry. TSND outperforms 80.65% of its industry peers.
- Measured over the past 3 years, the Average Return On Invested Capital for TSND is in line with the industry average of 8.64%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -15.47% | ||
| ROE | -88.45% | ||
| ROIC | 6.19% |
ROA(3y)-14.34%
ROA(5y)-17.9%
ROE(3y)-57.73%
ROE(5y)-55.06%
ROIC(3y)6.78%
ROIC(5y)N/A
1.3 Margins
- With a decent Operating Margin value of 15.36%, TSND is doing good in the industry, outperforming 74.19% of the companies in the same industry.
- In the last couple of years the Operating Margin of TSND has grown nicely.
- With a decent Gross Margin value of 51.80%, TSND is doing good in the industry, outperforming 67.74% of the companies in the same industry.
- In the last couple of years the Gross Margin of TSND has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 15.36% | ||
| PM (TTM) | N/A | ||
| GM | 51.8% |
OM growth 3YN/A
OM growth 5Y21.4%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y8.5%
GM growth 5Y-0.92%
2. TSND.CA Health Analysis
2.1 Basic Checks
- TSND has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
- Compared to 1 year ago, TSND has more shares outstanding
- TSND has more shares outstanding than it did 5 years ago.
- The debt/assets ratio for TSND is higher compared to a year ago.
2.2 Solvency
- TSND has an Altman-Z score of -1.07. This is a bad value and indicates that TSND is not financially healthy and even has some risk of bankruptcy.
- With a Altman-Z score value of -1.07, TSND is not doing good in the industry: 61.29% of the companies in the same industry are doing better.
- TSND has a debt to FCF ratio of 18.60. This is a negative value and a sign of low solvency as TSND would need 18.60 years to pay back of all of its debts.
- Looking at the Debt to FCF ratio, with a value of 18.60, TSND is in the better half of the industry, outperforming 61.29% of the companies in the same industry.
- TSND has a Debt/Equity ratio of 2.16. This is a high value indicating a heavy dependency on external financing.
- TSND has a worse Debt to Equity ratio (2.16) than 83.87% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.16 | ||
| Debt/FCF | 18.6 | ||
| Altman-Z | -1.07 |
ROIC/WACC0.59
WACC10.42%
2.3 Liquidity
- A Current Ratio of 1.38 indicates that TSND should not have too much problems paying its short term obligations.
- TSND's Current ratio of 1.38 is on the low side compared to the rest of the industry. TSND is outperformed by 64.52% of its industry peers.
- A Quick Ratio of 0.95 indicates that TSND may have some problems paying its short term obligations.
- With a Quick ratio value of 0.95, TSND is not doing good in the industry: 67.74% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.38 | ||
| Quick Ratio | 0.95 |
3. TSND.CA Growth Analysis
3.1 Past
- The earnings per share for TSND have decreased by -3.70% in the last year.
- The Revenue for TSND has decreased by -12.86% in the past year. This is quite bad
- The Revenue has been growing by 12.01% on average over the past years. This is quite good.
EPS 1Y (TTM)-3.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%109.09%
Revenue 1Y (TTM)-12.86%
Revenue growth 3Y1.69%
Revenue growth 5Y12.01%
Sales Q2Q%-11.02%
3.2 Future
- The Earnings Per Share is expected to grow by 16.69% on average over the next years. This is quite good.
- The Revenue is expected to grow by 4.42% on average over the next years.
EPS Next Y76.93%
EPS Next 2Y36.84%
EPS Next 3Y23.65%
EPS Next 5Y16.69%
Revenue Next Year0.1%
Revenue Next 2Y2.68%
Revenue Next 3Y3.13%
Revenue Next 5Y4.42%
3.3 Evolution
- The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. TSND.CA Valuation Analysis
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for TSND. In the last year negative earnings were reported.
- Also next year TSND is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, TSND is valued cheaply inside the industry as 80.65% of the companies are valued more expensively.
- Based on the Price/Free Cash Flow ratio, TSND is valued a bit cheaper than 64.52% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 19.88 | ||
| EV/EBITDA | 7.6 |
4.3 Compensation for Growth
- A more expensive valuation may be justified as TSND's earnings are expected to grow with 23.65% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y36.84%
EPS Next 3Y23.65%
5. TSND.CA Dividend Analysis
5.1 Amount
- No dividends for TSND!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
TSND.CA Fundamentals: All Metrics, Ratios and Statistics
TSX:TSND (4/17/2026, 7:00:00 PM)
0.89
-0.02 (-2.2%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)03-12 2026-03-12/amc
Earnings (Next)05-07 2026-05-07
Inst Owners39.22%
Inst Owner ChangeN/A
Ins Owners6.68%
Ins Owner ChangeN/A
Market Cap331.01M
Revenue(TTM)267.25M
Net Income(TTM)-86.23M
Analysts82.22
Price Target1.79 (101.12%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-58.73%
Min EPS beat(2)-348.18%
Max EPS beat(2)230.72%
EPS beat(4)1
Avg EPS beat(4)-188.13%
Min EPS beat(4)-614.39%
Max EPS beat(4)230.72%
EPS beat(8)1
Avg EPS beat(8)-154.88%
EPS beat(12)1
Avg EPS beat(12)-205.85%
EPS beat(16)3
Avg EPS beat(16)-297.98%
Revenue beat(2)1
Avg Revenue beat(2)-1.53%
Min Revenue beat(2)-3.35%
Max Revenue beat(2)0.28%
Revenue beat(4)1
Avg Revenue beat(4)-3.12%
Min Revenue beat(4)-6.15%
Max Revenue beat(4)0.28%
Revenue beat(8)1
Avg Revenue beat(8)-3.68%
Revenue beat(12)3
Avg Revenue beat(12)-2.59%
Revenue beat(16)3
Avg Revenue beat(16)-4.74%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)16.65%
EPS NQ rev (3m)16.65%
EPS NY rev (1m)-5.55%
EPS NY rev (3m)-5.55%
Revenue NQ rev (1m)-0.85%
Revenue NQ rev (3m)-2.4%
Revenue NY rev (1m)-1.25%
Revenue NY rev (3m)-1.77%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.91 | ||
| P/FCF | 19.88 | ||
| P/OCF | 11.25 | ||
| P/B | 2.48 | ||
| P/tB | N/A | ||
| EV/EBITDA | 7.6 |
EPS(TTM)-0.38
EYN/A
EPS(NY)-0.09
Fwd EYN/A
FCF(TTM)0.04
FCFY5.03%
OCF(TTM)0.08
OCFY8.89%
SpS0.98
BVpS0.36
TBVpS-0.66
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -15.47% | ||
| ROE | -88.45% | ||
| ROCE | 8.6% | ||
| ROIC | 6.19% | ||
| ROICexc | 6.72% | ||
| ROICexgc | 18.17% | ||
| OM | 15.36% | ||
| PM (TTM) | N/A | ||
| GM | 51.8% | ||
| FCFM | 4.56% |
ROA(3y)-14.34%
ROA(5y)-17.9%
ROE(3y)-57.73%
ROE(5y)-55.06%
ROIC(3y)6.78%
ROIC(5y)N/A
ROICexc(3y)7.22%
ROICexc(5y)N/A
ROICexgc(3y)21.93%
ROICexgc(5y)N/A
ROCE(3y)9.41%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y21.07%
ROICexc growth 3YN/A
ROICexc growth 5Y23.75%
OM growth 3YN/A
OM growth 5Y21.4%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y8.5%
GM growth 5Y-0.92%
F-Score4
Asset Turnover0.48
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.16 | ||
| Debt/FCF | 18.6 | ||
| Debt/EBITDA | 3.72 | ||
| Cap/Depr | 59.87% | ||
| Cap/Sales | 3.5% | ||
| Interest Coverage | 1.47 | ||
| Cash Conversion | 37.99% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.38 | ||
| Quick Ratio | 0.95 | ||
| Altman-Z | -1.07 |
F-Score4
WACC10.42%
ROIC/WACC0.59
Cap/Depr(3y)49.1%
Cap/Depr(5y)117.01%
Cap/Sales(3y)3.76%
Cap/Sales(5y)9.33%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-3.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%109.09%
EPS Next Y76.93%
EPS Next 2Y36.84%
EPS Next 3Y23.65%
EPS Next 5Y16.69%
Revenue 1Y (TTM)-12.86%
Revenue growth 3Y1.69%
Revenue growth 5Y12.01%
Sales Q2Q%-11.02%
Revenue Next Year0.1%
Revenue Next 2Y2.68%
Revenue Next 3Y3.13%
Revenue Next 5Y4.42%
EBIT growth 1Y43.55%
EBIT growth 3YN/A
EBIT growth 5Y35.98%
EBIT Next Year59.29%
EBIT Next 3Y25.39%
EBIT Next 5Y18.06%
FCF growth 1Y-55.56%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-43.27%
OCF growth 3YN/A
OCF growth 5YN/A
TERRASCEND CORP / TSND.CA Fundamental Analysis FAQ
What is the fundamental rating for TSND stock?
ChartMill assigns a fundamental rating of 2 / 10 to TSND.CA.
What is the valuation status of TERRASCEND CORP (TSND.CA) stock?
ChartMill assigns a valuation rating of 2 / 10 to TERRASCEND CORP (TSND.CA). This can be considered as Overvalued.
How profitable is TERRASCEND CORP (TSND.CA) stock?
TERRASCEND CORP (TSND.CA) has a profitability rating of 3 / 10.